Genome, Pharma Companies and Reagent - Clinical Research Informer

Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test

XTalks

AUGUST 18, 2020

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. This is significant because shortages of RNA extraction kits have been a recurrent issue since the beginning of the pandemic.

FDA Approval

FDA Approval Reagent RNA Genome

BioSpace Global Roundup, Oct. 15

The Pharma Data

OCTOBER 14, 2020

ERS Genomics – Ireland’s ERS Genomics signed an agreement with FASMAC Co., Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it. The patent is valid through 2038. Ltd of Japan.

Clinical Trials

Clinical Trials Clinical Trials Manufacturing In-Vivo

Clinical Research Informer

Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test

BioSpace Global Roundup, Oct. 15

Webinars

Stay Connected